Search research articles
Contact Us
Filters
Showing results (221-230 of 238) with videos related to
Page
of 24
Sort By:
International Journal of Peptides
|
January 24, 2014
Structural Features of the Peptide Homologous to 6-25 Fragment of Influenza A PB1 Protein
Vladimir V Egorov, Oleg V Matusevich, Aram A Shaldzhyan, et al.
Plos One
|
March 24, 2015
Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin
Liudmila A Stepanova, Roman Y Kotlyarov, Anna A Kovaleva, et al.
Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii
|
August 4, 2011
[Analysis of pandemic influenza in Russia as a part of the global process based on data of an influenza monitoring reference center]
A A Solomina, M P Grudinin, M Iu Eropkin, et al.
Gigiena I Sanitariia
|
April 25, 2001
[Effects of water use conditions on cancer morbidity]
P V Zhuravlev, V V Aleshnia, T V Sheliakina, et al.
Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii
|
June 14, 2000
[The etiological structure of the morbidity from influenza and other ARDs on the territory of Russia in the season of 1997-1998]
A A Sominina, O M Litvinova, V B Rodionova, et al.
Clinical and Vaccine Immunology : CVI
|
June 28, 2013
An inactivated, adjuvanted whole virion clade 2.2 H5N1 (A/Chicken/Astana/6/05) influenza vaccine is safe and immunogenic in a single dose in humans
Abylay R Sansyzbay, Marianna K Erofeeva, Berik M Khairullin, et al.
Genetika
|
June 20, 2015
[Genetic Cell Reprogramming: A New Technology for Basic Research and Applied Usage]
A N Bogomazova, E M Vassina, S I Kiselev, et al.
Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii
|
May 23, 2009
[Clinical trial of new inactivated influenza vaccine "Grifor"]
V V Zverev, O I Kiselev, S A Korovkin, et al.
Molekuliarnaia Biologiia
|
August 25, 2015
[Ebola hemorrhagic fever: Properties of the pathogen and development of vaccines and chemotherapeutic agents]
O I Kiselev, A V Vasin, M P Shevyryova, et al.
Antiviral Research
|
December 3, 2014
Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments
O V Matusevich, V V Egorov, I A Gluzdikov, et al.
Page
of 24
Search research articles
Search
Showing results (221-230 of 238) with videos related to
Sort By:
Page
of 24
International Journal of Peptides
|
January 24, 2014
Structural Features of the Peptide Homologous to 6-25 Fragment of Influenza A PB1 Protein
Vladimir V Egorov, Oleg V Matusevich, Aram A Shaldzhyan, et al.
Plos One
|
March 24, 2015
Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin
Liudmila A Stepanova, Roman Y Kotlyarov, Anna A Kovaleva, et al.
Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii
|
August 4, 2011
[Analysis of pandemic influenza in Russia as a part of the global process based on data of an influenza monitoring reference center]
A A Solomina, M P Grudinin, M Iu Eropkin, et al.
Gigiena I Sanitariia
|
April 25, 2001
[Effects of water use conditions on cancer morbidity]
P V Zhuravlev, V V Aleshnia, T V Sheliakina, et al.
Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii
|
June 14, 2000
[The etiological structure of the morbidity from influenza and other ARDs on the territory of Russia in the season of 1997-1998]
A A Sominina, O M Litvinova, V B Rodionova, et al.
Clinical and Vaccine Immunology : CVI
|
June 28, 2013
An inactivated, adjuvanted whole virion clade 2.2 H5N1 (A/Chicken/Astana/6/05) influenza vaccine is safe and immunogenic in a single dose in humans
Abylay R Sansyzbay, Marianna K Erofeeva, Berik M Khairullin, et al.
Genetika
|
June 20, 2015
[Genetic Cell Reprogramming: A New Technology for Basic Research and Applied Usage]
A N Bogomazova, E M Vassina, S I Kiselev, et al.
Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii
|
May 23, 2009
[Clinical trial of new inactivated influenza vaccine "Grifor"]
V V Zverev, O I Kiselev, S A Korovkin, et al.
Molekuliarnaia Biologiia
|
August 25, 2015
[Ebola hemorrhagic fever: Properties of the pathogen and development of vaccines and chemotherapeutic agents]
O I Kiselev, A V Vasin, M P Shevyryova, et al.
Antiviral Research
|
December 3, 2014
Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments
O V Matusevich, V V Egorov, I A Gluzdikov, et al.
Page
of 24